8-KThe WireStrategic
Results of Operations · Exit / Disposal Costs
Filed Mar 3, 2026 · 3mo ago · Accession 0001104659-26-022572
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Theravance Biopharma, Inc.
- Ticker
- TBPH
- CIK
- 1583107
- Form type
- 8-K
- Filing date
- Mar 3, 2026
- Report date
- Mar 3, 2026
- Document
- tm267846d1_8k.htm
- Size
- 266 KB